Fonte: Neuroimmunomodulation. Unidade: FMVZ
Assuntos: ALERGIA E IMUNOLOGIA, INFLAMAÇÃO, RECEPTORES IMUNOLÓGICOS, PROLACTINA
ABNT
OCHOA AMAYA, Julieta Esperanza et al. Short-term hyperprolactinemia reduces the expression of purinergic P2X7 receptors during allergic inflammatory response of the lungs. Neuroimmunomodulation, v. 25, n. 1, p. 34-41, 2018Tradução . . Disponível em: https://doi.org/10.1159/000489312. Acesso em: 01 nov. 2024.APA
Ochoa Amaya, J. E., Queiroz-Hazarbassanov, N., Namazu, L. B., Calefi, A. S., Tobaruela, C. N., Margatho, R., et al. (2018). Short-term hyperprolactinemia reduces the expression of purinergic P2X7 receptors during allergic inflammatory response of the lungs. Neuroimmunomodulation, 25( 1), 34-41. doi:10.1159/000489312NLM
Ochoa Amaya JE, Queiroz-Hazarbassanov N, Namazu LB, Calefi AS, Tobaruela CN, Margatho R, Palermo-Neto J, Oliveira APL de, Felício LF. Short-term hyperprolactinemia reduces the expression of purinergic P2X7 receptors during allergic inflammatory response of the lungs [Internet]. Neuroimmunomodulation. 2018 ; 25( 1): 34-41.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1159/000489312Vancouver
Ochoa Amaya JE, Queiroz-Hazarbassanov N, Namazu LB, Calefi AS, Tobaruela CN, Margatho R, Palermo-Neto J, Oliveira APL de, Felício LF. Short-term hyperprolactinemia reduces the expression of purinergic P2X7 receptors during allergic inflammatory response of the lungs [Internet]. Neuroimmunomodulation. 2018 ; 25( 1): 34-41.[citado 2024 nov. 01 ] Available from: https://doi.org/10.1159/000489312